Compound Detail
CHEMBL570930
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL570930 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | ISVODKXPQNTMCZ-ICFOKQHNSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
250.3
MW (Da)
3.09
ALogP
2
HBA
0
HBD
32.7
PSA (Ų)
0.77
QED
0
Ro5 Violations
1
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 5.2
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Transthyretin CHEMBL3194 | IC50 | 5.2 | 5.2 | 6300.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Transthyretin | IC50 | = | 6300.0 | nM | 5.2 | Inhibition of TTR mediated fibrillogenesis assessed as acid-induced protein aggr... | 19651509 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 19651509 | 10.1016/j.bmcl.2009.03.004 | Transthyretin | 3 |
Data from ChEMBL 36 via Core Engine